Streetbeat News

Revenues

GSK

PFE

Pfizer Inc (NYSE:PFE) has secured a major contract with the U.K. to supply millions of doses of its Abrysvo RSV vaccine, surpassing GSK Plc (NYSE:GSK). The contract includes over 3.5 million doses for older adults and 1.4 million doses for pregnant mothers over the next two years. This decision is a significant blow to GSK, which is in fierce competition with Pfizer in the RSV vaccine market.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 3:35 pm

CDNS

INTC

Cadence Design Systems (NASDAQ:CDNS) and Intel Foundry have announced key milestones in their strategic partnership, focusing on 3D-IC enablement, EDA flows, and IP development across Intel process nodes, starting with Intel 18A. The collaboration includes the availability of an advanced EMIB 2.5D packaging flow, enhancements to digital and custom/analog flows, and a comprehensive IP portfolio.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 3:33 pm

HYMTF

Hyundai Motor Co., Ltd.'s unionized workers in South Korea have voted in favor of potential strike action due to stalled wage and retirement age negotiations. The strike could disrupt production and impact Hyundai's short-term sales, especially in the U.S. market.

Portfolio Pulse from Lekha Gupta

June 24, 2024 | 3:32 pm

SNA

Snap-on (NYSE:SNA) has significantly outperformed the market over the past 15 years, delivering an average annual return of 16.13%. A $1000 investment in SNA 15 years ago would be worth $9,275.53 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 3:30 pm

V

Visa (NYSE:V) has significantly outperformed the market over the past 15 years, delivering an average annual return of 21.23%. A $1000 investment in Visa 15 years ago would be worth $17,754.53 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 3:30 pm

ALIM

ANIP

ANI Pharmaceuticals Inc (NASDAQ:ANIP) has agreed to acquire Alimera Sciences Inc (NASDAQ:ALIM) for $5.50 per share in cash and a contingent value right (CVR) of up to $0.50 per share. The deal, valued at approximately $381 million, includes the repayment of $72.5 million of Alimera's debt and is expected to close in Q3 2024. The acquisition will expand ANI's rare disease segment and international footprint, adding Alimera's products Iluvien and Yutiq to its portfolio. ANI expects significant revenue and EPS accretion from the deal.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 3:28 pm

CVX

Chevron announced plans for Q2 2024 buybacks between $2.5 billion and $3 billion. The company expects full-year production, including asset sales, to range from 3,245 MBOE/d to 3,338 MBOE/d. Estimated Q2 upstream turnarounds and downtime are about 65 MBOE/d, mainly due to TCO and Gulf of Mexico assets. Permian production in H1 is expected to be down less than 2% from Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 3:13 pm

BNBUSD

BNB's price has decreased by 3.39% in the past 24 hours to $566.52, continuing a week-long downward trend of -6.0%. Trading volume has increased by 36.0% over the past week, while the circulating supply has slightly decreased by 0.08%. BNB's market cap is currently ranked #4 at $86.91 billion.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 3:02 pm

DTE

Analyst ratings for DTE Energy (NYSE:DTE) over the past three months show a mix of bullish and bearish perspectives. The average 12-month price target is $117.17, with a high of $125.00 and a low of $111.00. Recent ratings include both raises and lowers from various analysts. DTE Energy faces challenges with a -14.26% decline in revenue, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 3:01 pm

IIPR

Cody Shandraw, president of Healing Realty Trust, discussed the role of real estate in the growth of psychedelic therapies on Benzinga’s Cannabis Insider podcast. Shandraw highlighted the importance of specialized facilities for treatments like MDMA-assisted therapy and mentioned his investment in Innovative Industrial Properties (NYSE:IIPR) as a pivotal moment. Healing Realty Trust aims to develop real estate solutions to support the expansion of psychedelic therapies, with potential future expansions and an IPO.

Portfolio Pulse from Patricio Liddle

June 24, 2024 | 3:01 pm